AdVita Lifescience was sold to RELIEF THERAPEUTICS Holding AG
RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief"), a biopharmaceutical company with its lead compound RLF-100TM (Aviptadil) in advanced clinical development to treat severe COVID-19 patients buys AdVita Lifescience GmbH ("AdVita"), a Germany-based, privately held pharmaceutical company developing effective products and strategies to improve the treatment and diagnosis of rare lung diseases.
RELIEF THERAPEUTICS Holding AG
Hoffmann & Partner
We are a leading independent professional services company based in Switzerland, offering a unique, integrated services model in the complex and specialist areas of valuations and mergers and acquisitions. We, the partners – Kaspar Kunz, Dr. Urs Breitenstein, Thomas Wenk, Marc Hoffmann und Patrick Schacher – attach great importance to deliver innovative solutions with true professionalism, commitment, transparency, integrity and personal customer care.